Medullary thyroid cancer other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Key Findings in Nuclear Imaging in Medullary Thyroid Cancer== | ==Key Findings in Nuclear Imaging in Medullary Thyroid Cancer== | ||
* Radioactive iodine: lesions do not concentrate radioactive iodine since the tumour does not arise from thyroid follicular cells | * Radioactive iodine: lesions do not concentrate radioactive iodine since the tumour does not arise from thyroid follicular cells | ||
FDG-PET: avid uptake | * FDG-PET: avid uptake | ||
Tl-201: It has been shown to concentrate Thallium-201 5 | * Tl-201: It has been shown to concentrate Thallium-201 5 | ||
I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan | * I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Endocrine system]] | |||
[[Category: | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Otolaryngology]] | ||
[[Category:Disease]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Types of cancer]] | |||
[[Category:Hereditary cancers]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:24, 16 November 2015
|
Medullary thyroid cancer Microchapters |
|
Differentiating Medullary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Medullary thyroid cancer other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Medullary thyroid cancer other diagnostic studies |
|
Medullary thyroid cancer other diagnostic studies in the news |
|
Risk calculators and risk factors for Medullary thyroid cancer other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Other diagnostic studies for medullary thyroid cancer include nuclear imaging, which demonstrates increased uptake of radioactive iodine at the areas of metastases.
Key Findings in Nuclear Imaging in Medullary Thyroid Cancer
- Radioactive iodine: lesions do not concentrate radioactive iodine since the tumour does not arise from thyroid follicular cells
- FDG-PET: avid uptake
- Tl-201: It has been shown to concentrate Thallium-201 5
- I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan